Findlay I N, MacLeod K, Ford M, Gillen G, Elliott A T, Dargie H J
Br Heart J. 1986 Mar;55(3):240-5. doi: 10.1136/hrt.55.3.240.
The antianginal effects of nifedipine 20 mg three times a day and atenolol 100 mg once a day singly and in combination were investigated in 16 patients with angina pectoris. The amount of work that could be done before angina and ST depression appeared was significantly increased by atenolol and the combination but not by nifedipine. At peak exercise the number of leads on a 16 point precordial electrocardiogram map that demonstrated greater than or equal to 1 mm ST segment depression was significantly reduced from a mean (SD) of 5.0 (0.4) on placebo to 3.7 (0.6), 2.8 (0.4), and 2.3 (0.7) on nifedipine, atenolol, and the combination respectively. Mean resting left ventricular ejection fraction, assessed by gated radionuclide ventriculography, did not change during any active treatment phase but increased significantly during exercise only on nifedipine and the combination. The nifedipine/atenolol combination was the most effective treatment, and the data suggest that nifedipine may be used to best advantage in combination with a beta blocker.
对16例心绞痛患者研究了硝苯地平每日3次每次20 mg和阿替洛尔每日1次100 mg单药及联合用药的抗心绞痛作用。阿替洛尔及联合用药可显著增加心绞痛和ST段压低出现前的做功量,而硝苯地平则无此作用。在运动高峰时,16点胸前心电图上显示ST段压低≥1 mm的导联数,从安慰剂组的平均(标准差)5.0(0.4),分别显著降至硝苯地平组的3.7(0.6)、阿替洛尔组的2.8(0.4)和联合用药组的2.3(0.7)。通过门控放射性核素心室造影评估的静息左心室射血分数,在任何积极治疗阶段均无变化,但仅在硝苯地平组和联合用药组运动时显著增加。硝苯地平/阿替洛尔联合用药是最有效的治疗方法,数据表明硝苯地平与β受体阻滞剂联合使用可能效果最佳。